Centre for Drug Research and Development
| Research and Commercialization Institute | |
| Industry | Biotechnology |
| Founded | 2007 |
| Headquarters | Vancouver, British Columbia, Canada |
Key people |
Gord McCauley, interim President and CEO Kathryn Hayashi, CFO Dr. Jason Crawford, Vice President, Scientific Operations Doug Erfle, Director, Project Management Barry Gee, Director, Communications Jon Jafari, Senior Director, Business Development Dr. Dave Rogers, Director, Intellectual Property |
Number of employees | 101 |
| Website |
Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada's national drug development and commercialization centre working in partnership with academia, industry, government and foundations. CDRD provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector — and ultimately into new therapies for patients. Canada's Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).
Divisions
- Target validation
- Screening
- Drug delivery
- Medicinal chemistry
- Pharmacology/toxicology
- Biologics
- External platforms
Funding
CDRD is supported by both public and private sector organizations looking to advance the successful commercialization of health research. These organizations include:
- The Canada Foundation for Innovation
- The Government of Canada's Networks of Centres of Excellence Program (which recognizes and supports CDRD as a Centre of Excellence in Commercialization in Research (CECR))
- The Province of British Columbia
- Michael Smith Foundation for Health Research
- Western Economic Diversification Canada
- Canadian Institute for Health Research
- Genome British Columbia
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline (GSK)
Participating institutions
CDRD currently has an existing portfolio of 209 supported research projects generated from its network of 100+ affiliated research institutions. These institutions represent Canada's top health research universities and research centres, as well as select international partner organizations. Collectively, these affiliated institutions invest several billion dollars in health-related research every year, and CDRD plays a pivotal role in translating that research into commercial products and economic returns including new jobs for British Columbia and Canada.
Key achievements
- 1,052 projects evaluated
- 828 potential projects / technologies reviewed
- 134 novel technologies (135+ research projects) supported
- 125+ principal investigators assisted
- 56 projects advanced towards commercialization and/or commercialized (51 ongoing)
- 14 technologies out-licensed to the private sector or under current development / management
- 7 spin-off companies launched
- 33 new patent families supported with CDRD data
- 29 collaborations on scientific publications
- $98 million in grant funding facilitated for PIs and their CDRD-related projects
- $60 million in international pharmaceutical sector investment attracted
- $220 million in incremental commercially focused health research being conducted as result of CDRD
- 168 postdoctoral fellows, co-op students and interns through the CDRD Training Program
- Over 300 hours in drug development and commercialization training offered